Date: 2012-12-04
Type of information: Company acquisition
Acquired company: Gambro (Sweden)
Acquiring company: Baxter (USA - IL)
Amount: 26.5 billion SEK (approximately $4.0 billion - € 3 billion)
Terms: * On September 6, 2013, Baxter International has announced that the company has successfully completed the acquisition of Gambro. The transaction further enhances Baxter's global renal leadership and provides the company with a comprehensive product and therapies portfolio to meet the needs of patients in the large and growing dialysis market. Brik Eyre has been named president of the combined Renal business and has been elected a corporate officer of Baxter by the company's Board of Directors. In his role, he will report to Robert M. Davis , president of Baxter's Medical Products business.Baxter International has entered into a definitive agreement to acquire Gambro AB , a privately held dialysis product company based in Lund, Sweden , for total consideration of 26.5 billion SEK (approximately $4.0 billion USD at current exchange rates - € 3 billion). The acquisition gives Baxter a comprehensive dialysis product portfolio, complements Baxter's global home dialysis offerings, and positions the company to better meet the evolving needs of the large and growing dialysis market. The transaction will be financed through a combination of cash generated from overseas operations and debt. The closing of the transaction is subject to regulatory approvals and other customary closing conditions and is expected to occur in the first half of 2013.
Details: Gambro is a global medical technology company focused on developing, manufacturing and supplying dialysis products and therapies for patients with acute or chronic kidney disease, with annual sales of approximately $1.6 billion in 2011. Its portfolio in the traditional chronic care segment consists of HD devices including advanced monitors, dialyzers, bloodlines, cyclers and dialysis solutions. Gambro's in-center HD devices include the ArtisTM system and the AK 96TM system. In the acute care segment, which includes CRRT and
treatment for fluid overload, among others, Gambro offers the Prismaflex® system used for the treatment of critically ill patients with acute kidney injury.
Related: dialysis products
